Gambetta RA[au] - Search Results

Year	Number of Results
1971	2
1972	1
1980	1
1981	1
1983	1
1986	2
1988	1
1989	2
1991	1
1992	2
1993	2
1994	3
1995	2
1996	1
1997	1
1998	1
2000	2
2023	0

1

The interaction of daunorubicin and doxorubicin with DNA and chromatin.

Zunino F, Di Marco A, Zaccara A, Gambetta RA. Zunino F, et al. Among authors: gambetta ra. Biochim Biophys Acta. 1980 Apr 30;607(2):206-14. doi: 10.1016/0005-2787(80)90073-8. Biochim Biophys Acta. 1980. PMID: 7370266

2

A differential interaction of doxorubicin and daunorubicin with human serum proteins.

Zunino F, Gambetta RA, Zaccara A, Carsana R. Zunino F, et al. Among authors: gambetta ra. Tumori. 1981 Oct 31;67(5):399-403. doi: 10.1177/030089168106700502. Tumori. 1981. PMID: 7324172

3

Inhibition of transforming activity of the ret/ptc1 oncoprotein by a 2-indolinone derivative.

Lanzi C, Cassinelli G, Pensa T, Cassinis M, Gambetta RA, Borrello MG, Menta E, Pierotti MA, Zunino F. Lanzi C, et al. Among authors: gambetta ra. Int J Cancer. 2000 Feb 1;85(3):384-90. Int J Cancer. 2000. PMID: 10652431 Free article.

4

Clavilactones, a novel class of tyrosine kinase inhibitors of fungal origin.

Cassinelli G, Lanzi C, Pensa T, Gambetta RA, Nasini G, Cuccuru G, Cassinis M, Pratesi G, Polizzi D, Tortoreto M, Zunino F. Cassinelli G, et al. Among authors: gambetta ra. Biochem Pharmacol. 2000 Jun 15;59(12):1539-47. doi: 10.1016/s0006-2952(00)00278-1. Biochem Pharmacol. 2000. PMID: 10799650

5

Lack of effect of glutathione depletion on cytotoxicity, mutagenicity and DNA damage produced by doxorubicin in cultured cells.

Capranico G, Babudri N, Casciarri G, Dolzani L, Gambetta RA, Longoni E, Pani B, Soranzo C, Zunino F. Capranico G, et al. Among authors: gambetta ra. Chem Biol Interact. 1986 Feb;57(2):189-201. doi: 10.1016/0009-2797(86)90037-2. Chem Biol Interact. 1986. PMID: 3955790

6

The daunorubicin-binding protein of Mr 54,000 is an aldehyde dehydrogenase and is down-regulated in mouse liver tumors and in tumor cell lines.

Banfi P, Lanzi C, Falvella FS, Gariboldi M, Gambetta RA, Dragani TA. Banfi P, et al. Among authors: gambetta ra. Mol Pharmacol. 1994 Nov;46(5):896-900. Mol Pharmacol. 1994. PMID: 7969077

7

Decreased drug accumulation and increased tolerance to DNA damage in tumor cells with a low level of cisplatin resistance.

Lanzi C, Perego P, Supino R, Romanelli S, Pensa T, Carenini N, Viano I, Colangelo D, Leone R, Apostoli P, Cassinelli G, Gambetta RA, Zunino F. Lanzi C, et al. Among authors: gambetta ra. Biochem Pharmacol. 1998 Apr 15;55(8):1247-54. doi: 10.1016/s0006-2952(97)00599-6. Biochem Pharmacol. 1998. PMID: 9719480

8

Protein kinase C activation and lipid peroxidation by doxorubicin analogues.

Gambetta RA, Banfi P, Lanzi C, Franzi A, Zunino F. Gambetta RA, et al. Tumori. 1989 Aug 31;75(4):358-61. doi: 10.1177/030089168907500411. Tumori. 1989. PMID: 2815343

9

Synthesis of alkyl chain-modified ether lipids and evaluation of their in vitro cytotoxicity.

Fos E, Suesa N, Borras L, Lobato C, Banfi P, Gambetta RA, Zunino F, Mauleón D, Carganico G. Fos E, et al. Among authors: gambetta ra. J Med Chem. 1995 Mar 31;38(7):1216-28. doi: 10.1021/jm00007a018. J Med Chem. 1995. PMID: 7707324

10

Interaction of some daunomycin derivatives with deoxyribonucleic acid and their biological activity.

Di Marco A, Zunino F, Silverstrini R, Gambarucci C, Gambetta RA. Di Marco A, et al. Among authors: gambetta ra. Biochem Pharmacol. 1971 Jun;20(6):1323-8. doi: 10.1016/0006-2952(71)90365-0. Biochem Pharmacol. 1971. PMID: 5165732 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results